becatecarin has been researched along with rebeccamycin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forenza, S; Long, BH; Matson, JA; Rose, WC; Vyas, DM | 1 |
| Anizon, F; Bailly, C; Laine, W; Moreau, P; Prudhomme, M; Sancelme, M | 1 |
| Flaherty, L; Heilbrun, LK; Hussain, M; Ivy, P; Jain, V; LoRusso, PM; Vaishampayan, U | 1 |
| Alvarado, Y; Borthakur, G; Bueso-Ramos, C; Cortes, J; Estrov, Z; Faderl, S; Giles, F; Ivy, P; Nebiyou Bekele, B; Ravandi-Kashani, F | 1 |
1 review(s) available for becatecarin and rebeccamycin
| Article | Year |
|---|---|
Discovery of antitumor indolocarbazoles: rebeccamycin, NSC 655649, and fluoroindolocarbazoles.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Carbazoles; Drug Design; Glucosides; Humans; Indoles; Neoplasms; Structure-Activity Relationship | 2002 |
2 trial(s) available for becatecarin and rebeccamycin
| Article | Year |
|---|---|
A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer.
Topics: Adult; Aged; Aminoglycosides; Carbazoles; Carcinoma, Renal Cell; Confidence Intervals; Female; Glucosides; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Survival Rate | 2003 |
Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignancies.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Biopsy; Bone Marrow; Carbazoles; Dose-Response Relationship, Drug; Female; Glucosides; Hematologic Neoplasms; Humans; Male; Middle Aged; Virus Diseases | 2008 |
1 other study(ies) available for becatecarin and rebeccamycin
| Article | Year |
|---|---|
Rebeccamycin analogues bearing amine substituents or other groups on the sugar moiety.
Topics: Amines; Aminoglycosides; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Deoxyribonucleases; Glucose; Glucosides; Glycosylation; Humans; Indoles; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2003 |